Clinical Trial Update: Continuous Application of Lisuride in Parkinson's Disease by Subcutaneous Infusion [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating continuous subcutaneous lisuride infusion for Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• lisuride (lisuride)

Snippet

Sponsor: Axxonis Pharma AG | Conditions: Parkinson's Disease | Phase 3 | Status: COMPLETED